Huadong Medicine Statistics

Total Valuation

Huadong Medicine has a market cap or net worth of CNY 57.63 billion. The enterprise value is 55.79 billion.

Market Cap	57.63B
Enterprise Value	55.79B

Important Dates

The next estimated earnings date is Friday, April 11, 2025.

Earnings Date	Apr 11, 2025
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Huadong Medicine has 1.75 billion shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	n/a
Shares Outstanding	1.75B
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.64%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.99%
Float	731.14M

Valuation Ratios

The trailing PE ratio is 17.95 and the forward PE ratio is 18.87. Huadong Medicine's PEG ratio is 1.27.

PE Ratio	17.95
Forward PE	18.87
PS Ratio	1.38
PB Ratio	2.60
P/TBV Ratio	3.48
P/FCF Ratio	22.09
P/OCF Ratio	n/a
PEG Ratio	1.27

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.87, with an EV/FCF ratio of 21.38.

EV / Earnings	17.37
EV / Sales	1.34
EV / EBITDA	11.87
EV / EBIT	14.54
EV / FCF	21.38

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.10.

Current Ratio	1.48
Quick Ratio	1.11
Debt / Equity	0.10
Debt / EBITDA	0.50
Debt / FCF	0.91
Interest Coverage	32.74

Financial Efficiency

Return on equity (ROE) is 14.78% and return on invested capital (ROIC) is 10.09%.

Return on Equity (ROE)	14.78%
Return on Assets (ROA)	6.71%
Return on Capital (ROIC)	10.09%
Revenue Per Employee	2.46M
Profits Per Employee	189,295
Employee Count	16,969
Asset Turnover	1.17
Inventory Turnover	5.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.76% in the last 52 weeks. The beta is 0.67, so Huadong Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-17.76%
50-Day Moving Average	35.70
200-Day Moving Average	31.87
Relative Strength Index (RSI)	29.23
Average Volume (20 Days)	9,972,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Huadong Medicine had revenue of CNY 41.71 billion and earned 3.21 billion in profits. Earnings per share was 1.83.

Revenue	41.71B
Gross Profit	13.72B
Operating Income	3.84B
Pretax Income	3.91B
Net Income	3.21B
EBITDA	4.62B
EBIT	3.84B
Earnings Per Share (EPS)	1.83

Full Income Statement

Balance Sheet

The company has 4.74 billion in cash and 2.37 billion in debt, giving a net cash position of 2.37 billion or 1.35 per share.

Cash & Cash Equivalents	4.74B
Total Debt	2.37B
Net Cash	2.37B
Net Cash Per Share	1.35
Equity (Book Value)	22.57B
Book Value Per Share	12.64
Working Capital	6.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.19 billion and capital expenditures -1.58 billion, giving a free cash flow of 2.61 billion.

Operating Cash Flow	4.19B
Capital Expenditures	-1.58B
Free Cash Flow	2.61B
FCF Per Share	1.49

Full Cash Flow Statement

Margins

Gross margin is 32.89%, with operating and profit margins of 9.20% and 7.70%.

Gross Margin	32.89%
Operating Margin	9.20%
Pretax Margin	9.38%
Profit Margin	7.70%
EBITDA Margin	11.07%
EBIT Margin	9.20%
FCF Margin	6.26%

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 2.13%.

Dividend Per Share	0.70
Dividend Yield	2.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	52.83%
Buyback Yield	-0.04%
Shareholder Yield	2.08%
Earnings Yield	5.57%
FCF Yield	4.53%

Dividend Details

Stock Splits

The last stock split was on June 21, 2019. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 21, 2019
Split Type	Forward
Split Ratio	1.2

Scores

Huadong Medicine has an Altman Z-Score of 4.7.

Altman Z-Score	4.7
Piotroski F-Score	n/a